Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2018 Opportunities, Business Strategies, Cost Structure, Service Provider, Product Segmentation, Shares, Forecast to 2023

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jan-2018   |    Format :PDF   |    Number of Pages : 93
This report studies the global Gastroesophageal Reflux Disease Therapeutics market, analyzes and researches the Gastroesophageal Reflux Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    AstraZeneca
    Eisai
    Takeda Pharmaceutical
    GlaxoSmithKline
    Johnson & Johnson
    Daewoong Pharmaceutical
    Ironwood Pharmaceuticals
    Rottapharm Madaus
    Peer Medical
    Reviva Pharmaceuticals

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Antacids
    H2 Receptor Blockers
    Proton Pump Inhibitors (PPIs)
    Pro-kinetic Agents
    Others

Market segment by Application, Gastroesophageal Reflux Disease Therapeutics can be split into
    Hospital Pharmacy
    Drug Stores
    General Stores
    Supermarkets

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025
1 Industry Overview of Gastroesophageal Reflux Disease Therapeutics
    1.1  Gastroesophageal Reflux Disease Therapeutics Market Overview
        1.1.1 Gastroesophageal Reflux Disease Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Gastroesophageal Reflux Disease Therapeutics Market by Type
        1.3.1 Antacids
        1.3.2 H2 Receptor Blockers
        1.3.3 Proton Pump Inhibitors (PPIs)
        1.3.4 Pro-kinetic Agents
        1.3.5 Others
    1.4 Gastroesophageal Reflux Disease Therapeutics Market by End Users/Application
        1.4.1 Hospital Pharmacy
        1.4.2 Drug Stores
        1.4.3 General Stores
        1.4.4 Supermarkets

2 Global Gastroesophageal Reflux Disease Therapeutics Competition Analysis by Players
    2.1 Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 AstraZeneca
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.1.5 Recent Developments
    3.2 Eisai
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.2.5 Recent Developments
    3.3 Takeda Pharmaceutical
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.3.5 Recent Developments
    3.4 GlaxoSmithKline
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.4.5 Recent Developments
    3.5 Johnson & Johnson
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.5.5 Recent Developments
    3.6 Daewoong Pharmaceutical
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.6.5 Recent Developments
    3.7 Ironwood Pharmaceuticals
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.7.5 Recent Developments
    3.8 Rottapharm Madaus
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.8.5 Recent Developments
    3.9 Peer Medical
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.9.5 Recent Developments
    3.10 Reviva Pharmaceuticals
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
        3.10.5 Recent Developments

4 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type and Application (2013-2018)
    4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2013-2018)
    4.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    4.3 Potential Application of Gastroesophageal Reflux Disease Therapeutics in Future
    4.4 Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics

5 United States Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    5.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    5.2 United States Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    5.3 United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

6 EU Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    6.1 EU Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    6.2 EU Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    6.3 EU Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

7 Japan Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    7.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    7.2 Japan Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    7.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

8 China Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    8.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    8.2 China Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    8.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

9 India Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    9.1 India Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    9.2 India Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    9.3 India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

10 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
    10.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
    10.2 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
    10.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
        11.1.2 EU Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
        11.1.3 Japan Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
        11.1.4 China Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
        11.1.5 India Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
        11.1.6 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
    11.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Type (2018-2025)
    11.3 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2018-2025)

12 Gastroesophageal Reflux Disease Therapeutics Market Dynamics
    12.1 Gastroesophageal Reflux Disease Therapeutics Market Opportunities
    12.2 Gastroesophageal Reflux Disease Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Gastroesophageal Reflux Disease Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Gastroesophageal Reflux Disease Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2013-2018)
    Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure EU Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type in 2017
    Figure Antacids Market Size (Million USD) and Growth Rate (2013-2018)
    Figure H2 Receptor Blockers Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Proton Pump Inhibitors (PPIs) Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Pro-kinetic Agents Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application in 2017
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacy (2013-2018)
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Drug Stores (2013-2018)
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in General Stores (2013-2018)
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Supermarkets (2013-2018)
    Table Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table AstraZeneca Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of AstraZeneca (2013-2018)
    Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Eisai Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Eisai (2013-2018)
    Figure Eisai Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Takeda Pharmaceutical Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical (2013-2018)
    Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table GlaxoSmithKline Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
    Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Johnson & Johnson Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
    Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Daewoong Pharmaceutical Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Daewoong Pharmaceutical (2013-2018)
    Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Ironwood Pharmaceuticals Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Ironwood Pharmaceuticals (2013-2018)
    Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Rottapharm Madaus Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Rottapharm Madaus (2013-2018)
    Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Peer Medical Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Peer Medical (2013-2018)
    Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Reviva Pharmaceuticals Basic Information List
    Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Reviva Pharmaceuticals (2013-2018)
    Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
    Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Product (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Product (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Product in 2017
    Table Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics
    Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure EU Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table EU Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure EU Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure EU Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table EU Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure EU Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure EU Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure China Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure India Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
    Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size and Growth Rate (2018-2025)
    Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Regions (2018-2025)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share (2018-2025)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Regions in 2025
    Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Figure EU Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Type (2018-2025)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2018
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2025
    Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application (2018-2025)
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application in 2018
    Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application in 2025

Latest News

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...

22-Mar-2018 | Service

Indian SMEs Can Now Opt For WhatsApp Business App For Better Connectivity

WhatsApp, a “Facebook” owned mobile-based application, has introduced its innovative and efficient feature “WhatsApp Business App” ...

13-Mar-2018 | Electrical & Electronic Device

Google Assistant-Powered Headphones to Be Launched Soon

Google is currently in news for its latest development that is a pair of headsets that will be powered by its very own Artificial Intelligence (AI) assistant. Currently, the headset market is on th ...

10-Mar-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

05-Mar-2018 | Aerospace & Defense

Can The Lens Free Camera Strengthen The Global Public Safety And Security Market?

A camera is a gadget that can help keep a track or capture some of the essential tasks or moments. In order to help the security officials easily carry out their task, the lens-free camera has been ...